.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Rheumatoid arthritis (RA) is a systemic autoimmune condition that leads to the progressive deterioration of bone and cartilage. Recent clinical evidence suggests that sex hormone-binding globulin (SHBG) plays a pivotal role in the pathogenesis of this disease. Specifically, this glycoprotein regulates the bioavailability of sex hormones, which are known to influence inflammatory pathways. Clinicians are increasingly recognizing the importance of SHBG in Rheumatoid Arthritis as a marker for both disease risk and long-term survival.
A comprehensive analysis of over 25,000 participants from the NHANES database indicates that elevated SHBG levels are a significant risk factor for RA. Researchers observed that patients with higher concentrations of this protein face a markedly reduced probability of survival. This association is particularly strong in male patients, suggesting a gender-specific impact on mortality. Furthermore, the study identifies a positive correlation between SHBG and markers of systemic inflammation, such as C-reactive protein (CRP).
The relationship between SHBG in Rheumatoid Arthritis and disease progression is partially mediated by frailty. Using a 49-item frailty index, investigators determined that frailty accounts for approximately 24.47% of the association between SHBG and RA. Therefore, assessing frailty in clinical practice is essential for a holistic understanding of patient risk. Moreover, the integration of these biomarkers into routine monitoring can help physicians identify high-risk individuals who may require more intensive management strategies.
Because RA is closely linked to cardiovascular complications, monitoring SHBG levels may provide valuable insights into a patient\'s cardiovascular health. Consequently, proactive screening could inform clinical management and improve prognostic accuracy. Additionally, healthcare providers should consider tailored interventions for male RA patients showing elevated SHBG levels. By addressing these factors early, clinicians can potentially mitigate the risk of adverse cardiovascular events and enhance the overall quality of life for their patients.
Yes, elevated serum SHBG concentrations are identified as a significant risk factor for the development of RA. This glycoprotein influences hormone levels that play a role in systemic inflammation.
Patients with higher SHBG levels demonstrate significantly lower survival rates. This correlation is notably more pronounced in male patients compared to female patients.
The frailty index acts as a partial mediator, explaining nearly a quarter of the relationship between SHBG levels and the presence of rheumatoid arthritis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Zheng X et al. Association between sex-hormone binding globulin and cardiovascular events in patients with rheumatoid arthritis. Clin Rheumatol. 2026 Feb 14. doi: 10.1007/s10067-026-07954-x. PMID: 41689735.
2. National Health and Nutrition Examination Survey (NHANES) 2013-2023. Analysis of Serum Glycoproteins and Autoimmune Outcomes.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Elevated SHBG levels are linked to increased RA risk and lower survival rates, particularly in men, according to a recent NHANES data analysis....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
